Bienvenidos a las Naciones Unidas
Next session: Reconvened 67th session (December 2024, dates TBC), Vienna.
67th session (14–22 March 2024), Vienna.
Report of the Commission on Narcotic Drugs on its sixty-seventh session [E/2024/28]
Resolutions/decisions adopted by the Council at the 2024 Management Segment as recommended by the Commission on its 67th session [E/2024/28, chap. I, sect. A] 
19(d) 
5 June 2024
Draft decision I: Report of the Commission on Narcotic Drugs on its sixty-seventh session and provisional agenda for its sixty-eighth session
Draft decision II: Report of the International Narcotics Control Board
Further resolutions/decisions adopted by CND on its 67th session [E/2024/28, chap. I, sect. B]:
High-level declaration by the Commission on Narcotic Drugs on the 2024 midterm review, following up to the Ministerial Declaration of 2019
Resolution 67/1: Promoting recovery and related support services for people with drug use disorders
Resolution 67/2: Promoting awareness-raising, education, training and data collection as part of a comprehensive approach to ensuring access to and the availability of controlled substances for medical and scientific purposes, including for the treatment of children, and ensuring their rational use
Resolution 67/3: Celebrating the tenth anniversary of the United Nations Guiding Principles on Alternative Development: effective implementation and the way forward
Resolution 67/4: Preventing and responding to drug overdose through prevention, treatment, care and recovery measures, as well as other public health interventions, to address the harms associated with illicit drug use as part of a balanced, comprehensive, scientific evidence-based approach
Decision 67/1: Inclusion of butonitazene in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
Decision 67/2: Inclusion of 3-chloromethcathinone (3-CMC) in Schedule II of the Convention on Psychotropic Substances of 1971
Decision 67/3: Inclusion of dipentylone in Schedule II of the Convention on Psychotropic Substances of 1971
Decision 67/4: Inclusion of 2-fluorodeschloroketamine in Schedule II of the Convention on Psychotropic Substances of 1971
Decision 67/5: Inclusion of bromazolam in Schedule IV of the Convention on Psychotropic Substances of 1971
Decision 67/6 Inclusion of 4-piperidone in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/7: Inclusion of 1-boc-4-piperidone in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/8: Inclusion of P-2-P methyl glycidic acid (“BMK glycidic acid”) (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/9: Inclusion of the methyl ester of P-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/10: Inclusion of the ethyl ester of P-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/11: Inclusion of the propyl ester of P-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/12: Inclusion of the isopropyl ester of P-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/13: Inclusion of the butyl ester of P-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/14: Inclusion of the isobutyl ester of P-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/15: Inclusion of the sec-butyl ester of P-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/16: Inclusion of the tert-butyl ester of P-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/17: Inclusion of the methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl and tert-butyl esters of P-2-P methyl glycidic acid in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 in the form of a footnote to P-2-P methyl glycidic acid
Decision 67/18: Inclusion of the ethyl ester of 3,4-MDP-2-P methyl glycidic acid (“PMK ethyl glycidate”) (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/19: Inclusion of the propyl ester of 3,4-MDP-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/20: Inclusion of the isopropyl ester of 3,4-MDP-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/21: Inclusion of the butyl ester of 3,4-MDP-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/22: Inclusion of the isobutyl ester of 3,4-MDP-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/23: Inclusion of the sec-butyl ester of 3,4-MDP-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/24: Inclusion of the tert-butyl ester of 3,4-MDP-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Decision 67/25: Inclusion of the ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl and tert-butyl esters of 3,4-MDP-2-P methyl glycidic acid (all stereoisomers) in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 in the form of a footnote to 3,4-MDP-2-P methyl glycidic acid
Reconvened 66th session (7- 8 December 2023), Vienna.
Report of the Commission on Narcotic Drugs on its reconvened sixty-sixth session [E/2023/28/Add.1]
Resolutions/decisions adopted by the Council at its 9th plenary meeting as recommended by the Commission on its reconvened 66th session [E/2023/28/Add.1, chap. I, sect. A] 19(d) 14 February 2024
Decision 2024/307: Report of the Commission on Narcotic Drugs on its reconvened sixty -sixth session
Further resolutions/decisions adopted by CND on its reconvened 66th session [E/2023/28/Add.1, chap. I, sect. B]
Resolution 66/5: Budget for the biennium 2024–2025 for the Fund of the United Nations International Drug Control Programme
Further resources: